Last Updated:
Name Designation Appointment Date Status
Nikolay Sinakevich

Appointed as Director since December 2008

Director 23-Dec-2008 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Psi Cro Pharma India Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Albertine Varone

Appointed as Director since April 2021

Director 19-Apr-2021 Current
Andrey Kozhemyakin

Appointed as Director since April 2021

Director 19-Apr-2021 Current
Srikanth Narasimhan

Appointed as Director since June 2015

Director 30-Jun-2015 Current

People Timeline

Explore the timeline of key personnel in Psi Cro Pharma India Private Limited's leadership journey.

Loading...
Contact Details
  • Address 2Nd Floor , Doddamane Building, No.19/1 Vittal Mallya Road, Bangalore North Karnataka, 560001, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Psi Cro Pharma India Private Limited through their registered address at 2Nd Floor , Doddamane Building, No.19/1 Vittal Mallya Road, Bangalore North Karnataka, 560001, India, or via their website at psi-cro.com. Social media links are also provided where applicable.
The current directors of Psi Cro Pharma India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • NIKOLAY SINAKEVICH
  • ALBERTINE VARONE
  • ANDREY KOZHEMYAKIN
  • SRIKANTH NARASIMHAN
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available